This study characterized the occurrence of carbapenem resistance of Acinetobacter
baumannii isolates in a tertiary care hospital in Saudi Arabia. From January 2010 until …

It has previously been shown that carbapenem-resistant Acinetobacter baumannii are
frequently detected in Saudi Arabia. The present study aimed to identify the epidemiology …

Background and objective Acinetobacter baumannii (A. baumannii) is a common
nosocomial pathogen, which developed multi-drug-resistance to different classes of …

Background In the last decade, incidences of carbapenem‐resistant Acinetobacter
baumannii have been increasingly reported worldwide. Consequently, A. baumannii was …

The increasing number of carbapenem-resistant Acinetobacter baumannii clinical isolates is
a major concern, which restricts therapeutic options for treatment of serious infections …

Carbapenem-resistant Acinetobacter baumannii is a major health problem worldwide,
especially in intensive care units (ICUs). This study aimed to detect the prevalence of A …

Objectives During routine diagnostic laboratory work, the clinical microbiologist observed an
increase of Acinetobacter baumannii isolates with three different carbapenem susceptibility …

The molecular epidemiology and mechanisms of resistance of carbapenem-resistant
Acinetobacter baumannii (CRAB) were determined in hospitals in the states of the …

The American Centers for Disease Control and Prevention (CDC) recognizes Acinetobacter
baumannii as a source of global outbreaks and epidemics especially due to its increasing …

Background Antibiotic use is largely under-regulated in Egypt leading to the emergence of
resistant isolates. Carbapenems are last resort agents to treat Acinetobacter baumannii …